Background
Increased levels of soluble E-selectin (sE-selectin) and soluble intercellular cell adhesion
molecule-1 (sICAM-1) have been reported in patients with psoriasis vulgaris compared with
controls.
Objective
The aim of this study was to investigate the effects of narrow-band ultraviolet-B (NB-UVB)
phototherapy on sE-selectin and sICAM-1 serum levels in patients with psoriasis vulgaris.
Patients and methods
This case–control study included 30 patients with psoriasis vulgaris and 20 apparently healthy
participants as a control group. Both patients and controls were subjected to full history taking,
dermatological examination, and measurement of sE-selectin and sICAM-1 using enzymelinked immunosorbent assay kits. In the patient group, sE-selectin and sICAM-1 were measured
after treatment with NB-UVB phototherapy, and the response was assessed by the Psoriasis
Area and Severity Index (PASI) score. sE-selectin and sICAM-1 serum levels were compared
before and after treatment and correlated with PASI scores.
Results
In this study, sE-selectin and sICAM-1 serum levels were significantly higher in the patient group
than in the control group (P = 0.001 for both). There were statistically significant reductions in
sE-selectin and sICAM-1 serum levels after NB-UVB phototherapy (P = 0.001 for both), but
still the levels were higher than those of controls. PASI scores significantly decreased after
treatment, confirming the efficacy of NB-UVB phototherapy. Both sE-selectin and sICAM-1
serum levels were positively correlated with PASI scores before and after NB-UVB phototherapy
(P = 0.001 for both).
Conclusion
The present study emphasizes the complex nature of the roles played by cell adhesion
molecules in the immune-pathogenesis of psoriasis and the effect of NB-UVB phototherapy
on their values in relation to the PASI score. Also, results of this study provide a rationale for
the possible application of sE-selectin and sICAM-1 measurements as biomarkers of psoriasis
activity and predictors of possible exacerbation. |
